Telemaque Lavidas

Executive Board Member

Born in New York, USA and raised in Athens, Greece, he holds a BA economics degree from Columbia University, NY. In 2003, he joined Lavipharm Laboratories, the R&D arm in the USA, as Assistant Project Manager. In 2006, he assumed the position of Business Development Director and in 2009 he returned to Greece, where up to 2013 he managed all commercial operations of the Group as Chief Commercial Officer (CCO), responsible for five Business Units (BUs), Pharma Rx, ConsumerHealth, International, Wholesaling and 3rd Party Logistics, and pharmacy network services (Pharma PLUS). In 2013, he founded Mediterra, a fast-growing health food company based in NY. In 2021, he returned to Greece and he took helm of the Lavipharm Group, where he serves as Executive Board Member. He is a member of the General Committee of the Federation of Enterprises and Industries (SEV) and the Hellenic Association of Entrepreneurs (EENE). He is fluent in Greek, English, and French.

Telemaque Lavidas represents the 4th generation of the Lavidas family in the pharma industry, while he continues to perpetuate the pharmaceuticals business know-how successfully.

Panagiotis Giannouleas

Chief Operations Officer & Country Manager

Born in Piraeus, he holds a B.Sc. in Computer Science & Engineering from La Verne University, California, U.S.A.. He started his career in 1996 at Boehringer Ingelheim Hellas as a Medical Representative, he then became Head of the CRM & Business Planning Department, and at a young age he was promoted to Sales Manager. In 2008, he moved to Faran as Marketing and Sales Manager, and from 2012 until joining Lavipharm he was the General Manager of Angelini Pharma Hellas. He has served as a board member of the Federation of Companies active in selfcare medicines, while he is an elected board member of SFEE (Hellenic Association of  Pharmaceutical Companies), appointed as Treasurer. 

Vassilis Baloumis

Chief Financial Officer

Βorn in Athens, he is a graduate in Business Administration of the Athens University of Economics and he holds an Executive MBA from the same University. He started his professional career in 1992 as a Financial Controller at Papastratos SA where he was promoted to Accounting Director. In 2004, he continued his career at LAMDA Development as a Financial Controller and two years later, he was promoted to Chief Financial Officer, a position he held until 2021. 

Mariza Antonaki

Human Resources Director (HRD)

Βorn in Athens, she is a graduate in Psychology at the American College of Greece (Deree College) and she holds a Masters’ degree in the field of Organizational Psychology from the University of London. She is an Associate Certified Coach from the ICF. She started her professional career in 1999 as Global Human Resources Consultant at Hay Group, with broad expertise in the Pharmaceutical sector. In Greece, she worked as HR Executive Manager at HELPE Group and as HR Director at Mitsis Hotels Group. She has also undertaken the role of HR Director and Internal Communication at the multinational organization Unilever.  

Aggelos Doumouras

Head of Pharma PLUS

Βorn in Athens, he holds a B.Sc. in Economics & Finance from University of Indianapolis, Athens Campus. He started his professional career in 2002, working in the  Stock & Currency Exchange markets until 2005, when he shifted to the Consumer Healthcare Industry, where he evolved in various positions until 2021. During the last 16 years, he assumed multiple commercial roles and was involved on high complexity projects through his employment at major global companies, such as Johnson & Johnson and  Glaxo Smith Kline in Grece. He joined Lavipharm as Head of Pharma PLUS S.A., the Group’s subsidiary engaged in the development of a banner pharmacy model nationwide. 

Panagiotis Kousoulis

Operations Director

Born in Elika Lakonia in Greece, he is  a graduate Chemical Engineer of  N.J. Institute of Technology, Newark New Jersey. Additional studies include Polymers engineering and TQM. 

He started his professional career in 1985 as Production Engineer at Liquid Carbonic Corporation USA. He worked his way in several chemical/pharmaceutical companies as a Process Engineering and a Production Manager and later as Manager of Operations. 

In 1999, he returned to Greece and took the management of Lavipharm’s plant. In 2022, he was promoted to Operations Director.

Ilias Konstantopoulos

Head of Marketing & Sales CHC

Born in Athens, he holds a BA in Business Administration of the American College of Greece, and he is undergraduate of the MBA program of “Heriot Watt” Edinburgh Business School. His professional experience begun in the Mass market at Minerva Edible Oils Enterprises, but he evolved mainly in the pharmaceutical industry. In 2005, he joined L’Oréal Cosmetique Active as Customer Manager and he continued for 11 years in the commercial departments of Johnson & Johnson Hellas in several roles with increased responsibilities. His next career step was the position of Sales Manager OTC Division in Gerolymatos International before joining Lavipharm Hellas in 2020.

Eleana Nikolopoulou

Head of Legal & Compliance

Born in Athens, she is a lawyer, a graduate of the Law School at the National and Kapodistrian University of Athens and she holds a LL.M. from the University of Munich. She is also an accredited mediator and a certified DPO. She started her professional career in 2000 as Legal Advisor at the construction company Hochtief. From 2002 to 2019, she was a legal advisor at companies active in the finance sector, initially at the insurance company Eurolife, followed by Eurobank and Viva Wallet. 

Xenofon Economou

Head of Internal Audit

Born in Ioannina, Greece, he holds a BA in Business Administration of the Athens University of Economics, a M.Sc. in Banking and Finance from the Piraeus University and an MBA from ALBA, Greece. In 2007, he started his professional career as a Financial Officer in the shipping company Naftotrade Shipping & Commercial and in 2012 he joined G&A Chantzikonsta Foundation. In 2015, he worked as Internal Procedure Manager in P.G NIKAS ABEE and since 2016 he exercises the profession of Internal Auditor. 

Ligia Panaitescu

R&D Director

Born in Cluj, Romania, she is a graduate of the Chemical Engineering Department at the Polytechnic School of the “Babes-Bolyai” University of Cluj, with a specialization in the Technology of Organic Substances. She also holds a master’s degree in Pharmaceutical Technology from the National and Kapodistrian University of Athens and an MBA from Alba Graduate Business School of the American College in Greece (ACG). She started her professional career in 1994 in the R&D department at Lavipharm, initially as R&D Scientist in Transdermal Delivery Systems and then, as R&D Manager. She continued her career at Famar as Head of New (Dermocosmetic) Product Development and Septona as R&D Director. In 2019, she retuned to Lavipharm as R&D Director. 

Dr. Emmanouil Petrou

Head of Medical Affairs, Lavipharm Hellas

Born in Piraeus, Greece, he received his Medical Degree from Masaryk University, Brno, Czech Republic. He completed the specialty of Cardiology at the Onassis Cardiac Surgery Center in Greece, he earned a Master’s Degree in Health Management from the University of Piraeus, and he is a PhD candidate at the University of Athens Medical School. In the Pharmaceutical Industry, he has gained experience at Angelini Pharma Hellas, as Medical Advisor, at GE Healthcare, as Medical Manager Southeastern Europe, and at Innovis Pharma, as Senior Medical Advisor. Currently, he is holding the position of Head of the Medical Affairs Department at Lavipharm Hellas S.A.

Aristeidis Polyvos

Head of Marketing Rx & Oncology, Lavipharm Hellas

Born in Athens, he graduated from the National & Kapodistrian University of Athens (NKUA) with a Bachelor degree in Biology (BSc). He also holds an International MBA degree with a focus on Strategy and Marketing from the Athens University of Economics and Business (AUEB). He started his career in 2001 as a Medical Representative at Boehringer Ingelheim Hellas. In 2005, he was promoted to Product Portfolio Manager Cardiovascular and, in 2013, he took over as BU Manager Oncology & Hepatitis. In 2014, he continued as Product Portfolio Manager Cardiovascular at Angelini Pharma Hellas and, in 2016, he took over as National Sales Manager Hospital Department. From 2018 until 2019, he took over as Marketing Hospital & Business Development Manager. In 2020,  he joined Lavipharm. 

Dr. Katerina Tsardaka

New Ventures and Corporate Business Development Director

Βorn in Athens, she is a graduate of the School of Pharmacy of the Kapodistrian University of Athens and holds a PhD from the University of Bath, UK. She started her professional career at Lavipharm’s R&D in 1991, contributing to the development of a wide range of products. In 2000, as Associate Director at Lavipharm’s Research Centre in NJ, USA, she was responsible for the development of OCR products. In 2002, as Intellectual Property, Research and Scientific Support Manager, she assumed, among others, the coordination of Lavipharm’s patents portfolio. In 2008, she joined Lavipharm’s Commercial operations as Business Development Manager, managing collaborations with third parties and supporting in-licensing and out-licensing activities. In 2012, she was promoted to Business Development Director and undertook the responsibility of the company’s exporting activities, also holding the position of Head of BU International until June 2021. Since then, as New Ventures and Corporate Business Development Director, she has been driving the company’s growth in the short, medium and long-term future.

Thomas Tseronis

Head of Sales Rx (ΗOS)

Born in Athens, he is a graduate of  Sports Science from the National Kapodistrian University of Athens and holds an Executive MBA from the University of Piraeus. He entered the pharmaceutical industry in 2014 as a Medical Sales Representative Rx in the sales department of Angelini Pharma Hellas SA and was subsequently promoted to the position of District Manager Rx. In 2020, he continued his career at Lavipharm Hellas as Head of Sales Rx.

Bill Tsonis

Quality Director & Qualified Person (QP)

Born in Kalamata, Greece, he holds a BSc degree in Biology from Loyola University of Chicago. He started his professional career in 1989 as a Microbiologist at Organon Teknika, in the Quality Control laboratory of vaccines and later was promoted to Laboratory Supervisor. In 1994, he continued his career at Hudson RCI as a Laboratory Manager and in 1999, as a Quality Assurance Manager. Later, in 2000, he served as a Compliance Manager at Abbott Laboratories. After his return to Greece, in 2002 continued his carrier as a Quality Assurance Manager at Lavipharm. In 2015, he was promoted to his current position as a Quality Director. 

Katerina Fragioudakis

Corporate Communications Director

Born in Athens, she is a graduate of the National and Kapodistrian University of Athens, School of Philosophy, Department of French Language and Literature. She started her professional career at A.A. Petsetaki S.A., a plastics processing company, at the Chairman & CEO Office. In 1997, she joined Lavipharm, initially at the Corporate Affairs and Business Development Department. While working, she received her Master’s degree in Business Administration (MBA) from the ALBA Graduate Business School. In 2001, she was promoted to Head of Chairman’s Office, responsible for its operations  in Greece, the USA and France, while in 2004 she was also appointed Head of Corporate Communications Department, leading a team of 7 professionals in total. In 2014, she was promoted to Chairman’s Office Director & Corporate Communications. Today, she is Corporate Communications Director of the Group. She is a member of the European Association of Communications Directors (EACD).

Theodora Chavela

Regulatory Affairs Director & Head of Market Access

Βorn in Athens, she is a graduate in Chemistry of the National and Kapodistrian University of Athens, specializing in analytical chemistry. She started her professional career in 2005 as a Regulatory Affairs Officer at REMEK Pharmaceuticals S.A. and in 2007 took over the management of the regulatory affairs department of ALAPIS S.A., as Regulatory Affairs Manager. In 2011, she continued her career at TEVA Pharmaceuticals Hellas S.A. as Senior Regulatory Affairs Officer, and since 2017 she has been a member of the regulatory affairs department of Lavipharm, initially as Regulatory Affairs Specialist and since 2018 as Regulatory Affairs Director & Head of Market Access.

Thanassis Christodoulou

Head of Lavipharm Active Services (LAS)

Born in Athens, he is a graduate of the School of Business Administration of Thessaloniki, as well as of the Industrial School of Economics at the same city. He started his professional career in 1987 as supervisor of the customer services and  credit control department at Lavipharm and a few years later became director of the Department. Between 1997 and 2004, he was promoted to sales manager at first and to purchase and sales manager of  Lavipharm Active Services S.A later. 

Since 2011, he holds the position of General Manager at Lavipharm Active Services S.A.

Ruud Van Anraat

Head of BU International

Βorn in Rotterdam, the Netherlands, he has graduated from the Technical University Chemistry in Rotterdam. He started his professional career in 1986 as Sales Manager at DSM and switched to the life science industry in 1991. Ever since, he has been active in the generic and the branded generic pharmaceutical industry in various executive positions in different organizations in Belgium (MD -Teva Belgium, CCO – Alter Pharma), Switzerland (CCO -Acino AG, Head of Analytical Service – Solvias), France (President – Acino SAS), and Germany (Global Director BD 6 Operations – Pharma Bavaria). In his 35-year career, the focus has been on general management and building and maintaining international business in Europe, Asia, Latin America, and Middle East regions. Aside leading Marketing & Sales organizations, he was active for many years in in/out licensing and in Business Development. Between 2002 and 2010, he was active as Chairman for the Belgian Generic Federation and got involved in Public Affairs activities on a national (Belgian) and pan-European level (EU-institutions). Since June 2021, he engaged himself with Lavipharm on a full-time base being an independent contractor.